{
  "report_rows": [
    {
      "kpi": "Adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.49 vs. cons $4.43",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net interest income",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.11B vs. cons $4.09B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$6.42B vs. cons $6.39B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Full-year net interest income growth",
      "prediction": "BETTER",
      "answer": "guide ~15.0% vs. cons 14.7% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year total revenue growth",
      "prediction": "BETTER",
      "answer": "guide ~11.5% vs. cons 11.1% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Second-half net interest margin",
      "prediction": "BETTER",
      "answer": "guide ~3.04% vs. cons 3.02% (2H2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Full-year core noninterest-expense growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~7.0% vs. cons 7.0% (FY2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.8,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Core EPS ~$4.49 versus $4.43 and FY2026 NII growth guide ~15.0% versus 14.7% support upward 2026\u20132027 estimate revisions, while 2H2026 NIM ~3.04% versus 3.02% validates the structural repricing thesis.",
  "day5_confidence": "MEDIUM"
}